Research / CVV / Fundamental state Inspectable configuration
State dimensions Filing 0001641172-25-009937 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
2.97% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.54% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-27.20% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
68.96% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
24.49% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
32.41% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
3.23% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
9.39% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
3.17% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 12 states History building
Sep 30, 2023 0/8 normalized Level 3 Dec 31, 2023 0/8 normalized Level 3 Mar 31, 2024 0/8 normalized Level 3 Jun 30, 2024 0/8 normalized Level 3 Sep 30, 2024 0/9 normalized Level 3 Dec 31, 2024 0/9 normalized Level 3 Mar 31, 2025 0/9 normalized Level 3 Jun 30, 2025 0/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 7/8 normalized Level 3 Jun 30, 2026 7/8 normalized Level 3 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 1.00%
Current 2.97%
Delta 1.97% Capex Intensity Increased
Previous 0.39%
Current 0.54%
Delta 0.15% Cash Generation Decreased
Previous -5.54%
Current -27.20%
Delta -21.66% Growth Increased
Previous 11.48%
Current 68.96%
Delta 57.48% Inventory Pressure Increased
Previous 7.87%
Current 24.49%
Delta 16.63% Margin Increased
Previous 23.56%
Current 32.41%
Delta 8.85% Profitability Increased
Previous -8.99%
Current 3.23%
Delta 12.22% R And D Intensity Decreased
Previous 9.77%
Current 9.39%
Delta -0.38% Sbc Intensity Decreased
Previous 3.96%
Current 3.17%
Delta -0.78% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.